glp 1 for cardiovascular disease Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs Cardiovascular and mortality outcomes with

That guidance is based on general probiotic research suggesting that taking probiotics with or shortly before eating may help some bacterial strains survive stomach acid, since food can buffer gastric acidity

The I-Team found many people believe they are taking generic versions of Ozempic, Wegovy and Mounjaro, when in fact they are not

The complex pathophysiology and the metabolic risk factors shared between type 2 diabetes, obesity, CKD and cardiovascular disease have led to the concept of a cardiovascularkidneymetabolic (CKM) syndrome

These metabolites have been recognized in a wide sense to play a considerable role in shaping gut microbiota composition, selectively promoting the growth of beneficial bacteria like Bifidobacteria and Lactobacilli , while inhibiting the growth of pathogenic species such as Clostridium and Enterobacteriaceae (Krishnamurthy et al., 2023)

What Medical Conditions May Support Treatment

It important to not titrate your dose too quickly and only increase the dose if side effects are manageable and you are not noticing appetite suppression on the current dose